Oncology Data Solutions for HEOR & Research

Research ready real-world data with the depth and breadth to generate real-world evidence
A graphic of colorful concentric circles
Research-ready oncology data that supports evidence generation

Ontada is uniquely positioned to provide the up-to-date, granular and robust data required to reach more-informative evidence and research insights faster. Our research-ready clinical data is available for immediate analysis, overcoming the cumbersome hurdles associated with harmonizing claims data or chart reviews.

Our research oncology data solutions, ON.OutcomesView and ON.JourneyView, integrate the quality real-world data (RWD) and state-of-the-art analysis needed for evidence generation. Ontada’s comprehensive clinical data also allows researchers to follow granular trends over the entire patient journey, creating powerful evidence for stakeholders, reimbursement and opportunity identification.

Empowering oncology breakthroughs with RWD and insights

350+
Real-world evidence (RWE) publications
1.4M+
Patient records available for research
85+
Oncology indications supported, including rare cancers
Generate oncology evidence, evaluate clinical decisions, and analyze diverse populations with ON.OutcomesView

Ontada’s research-ready data provides a rich, detailed view of patient demographics, diagnosis, testing, treatment choices and outcomes. ON.OutcomesView allows researchers to examine disease progression patterns, treatment failures and molecular markers to pinpoint areas where improvements are needed and inform evidence-based strategies. Clients can also monitor near real-time adaptations to changing standards of care and understand treatment performance to expedite analyses, publications and stakeholder engagement discussions.

A top down view of a traffic roundabout
Get evidence on the full patient journey for critical intervention opportunities with ON.JourneyView

ON.JourneyView is uniquely positioned to efficiently analyze patient-level EHR data to reveal patient journey insights. In doing so, researchers can produce a detailed view of patient care to identify critical treatment junctures and potential means to improve patient-centered care. ON.JourneyView leverages AI- and ML-enhanced common data models to generate actionable insights, speed evidence generation and adjust research based on the latest clinical evidence.

A graphic of colorful concentric circles

Leverage Ontada’s up-to-date, clinical RWD to generate better evidence faster

Transparent results

Understand, explain, defend, and trust results by leveraging AI- and ML-enhanced common data models to enable complete, traceable, and interoperable insights, accelerating speed to evidence

Rapid insights

Quickly adjust your research to the latest clinical evidence, reflecting near real-time adaptation to changing standards of care

Representative data

Benefit from the depth and breadth of our clinical record data to deliver tailored solutions that address the unique needs of oncology

Point-of-care technology

Monitor point-of-care decisions for robust evidence generation

Population-based evidence

Inform evidence-based strategies by leveraging diverse outcomes data in specific patient populations

Patient-care insights

Examine patterns in disease progression, treatment failures, and molecular markers to pinpoint areas where new interventions or improvements are needed 

Supporting research across the product lifecycle

Pre-launch
Pre-launch
Pre-launch
  • Understand and follow patients from early-stage diagnosis through entire treatment journey
  • Rapidly conduct RWD research to identify endpoints reflective of up-to-date clinical practice patterns, including biomarker testing, utilization rates, recurrence-free survival, and overall survival
  • Determine the most effective treatment protocols and where further research or education may be needed
Launch
Launch
Launch
  • Identify all patients diagnosed with a specific cancer in The US Oncology Network
  • Utilize detailed patient-level data for precise analysis, ensuring diverse patient populations are represented
  • Uncover the rationale behind clinical decisions for a complete understanding of testing and treatment patterns
Post-launch
Post-launch
Post-launch
  • Gather evidence that can expand indications to move line of therapy
  • Evaluate broader populations to understand areas of unmet need relative to standard of care and generate evidence that support opportunities for expanded utilization of products
  • Generate evidence where products will produce improved outcomes across specific patient populations
Pre-launch
  • Understand and follow patients from early-stage diagnosis through entire treatment journey
  • Rapidly conduct RWD research to identify endpoints reflective of up-to-date clinical practice patterns, including biomarker testing, utilization rates, recurrence-free survival, and overall survival
  • Determine the most effective treatment protocols and where further research or education may be needed
Launch
  • Identify all patients diagnosed with a specific cancer in The US Oncology Network
  • Utilize detailed patient-level data for precise analysis, ensuring diverse patient populations are represented
  • Uncover the rationale behind clinical decisions for a complete understanding of testing and treatment patterns
Post-launch
  • Gather evidence that can expand indications to move line of therapy
  • Evaluate broader populations to understand areas of unmet need relative to standard of care and generate evidence that support opportunities for expanded utilization of products
  • Generate evidence where products will produce improved outcomes across specific patient populations
Talk to an expert

Evidence generation requires sufficient breadth and depth to provide actionable insights into oncology patient care. Ontada’s research data products can remove clinical data and analysis barriers to furnish researchers with the relevant, up-to-date RWE they require.

top